有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[(1R)-2-amino-1-(4-fluorophenyl)ethyl]sulfanylpyrimidine-4,6-diamine | —— | C12H14FN5S |
|
—— | (1S,2S)-1-(4-methylphenyl)-1-thiophen-2-ylsulfanylbutan-2-amine | —— | C15H19NS2 |
|
—— | (2R)-2-(2,5-dimethylphenyl)sulfanyl-2-(4-fluorophenyl)ethanamine | —— | C16H18FNS |
|
—— | (1R,2S)-1-(4-methylphenyl)-1-(1-methylpyrazol-4-yl)sulfanylbutan-2-amine | —— | C15H21N3S |
|
—— | 2-[(1S)-2-amino-1-(4-fluorophenyl)ethyl]sulfanyl-6-methyl-1H-pyrimidin-4-one | —— | C13H14FN3OS |
|
—— | (1S,2R)-1-(4-fluorophenyl)-1-thiophen-2-ylsulfanylbutan-2-amine | —— | C14H16FNS2 |
|
—— | (2R)-2-[[4-amino-5-(trifluoromethyl)-1,2,4-triazol-3-yl]sulfanyl]-N-cyclohexyl-N,3-dimethylbutanamide | —— | C15H24F3N5OS |
|
—— | (2R)-2-(2,4-dimethylphenyl)sulfanyl-2-(4-fluorophenyl)ethanamine | —— | C16H18FNS |
|
—— | 2-[(4-Bromophenyl)sulfanyl]-5-[(3,5-dimethylpiperidin-1-YL)sulfonyl]-N-[2-(morpholin-4-YL)ethyl]benzamide | —— | C26H34BrN3O4S2 |
|
—— | (1R,2S)-1-(4-methylphenyl)-1-phenylsulfanylbutan-2-amine | —— | C17H21NS |
|
—— | (2S)-2-(3,4-dimethylphenyl)sulfanyl-2-(4-fluorophenyl)ethanamine | —— | C16H18FNS |
|
—— | (2S)-2-(4-fluorophenyl)-2-(4-methylphenyl)sulfanylethanamine | —— | C15H16FNS |
|
—— | (1S,2R)-1-(4-methylphenyl)-1-(1-methyltetrazol-5-yl)sulfanylbutan-2-amine | —— | C13H19N5S |
|
—— | 2-(4-bromophenyl)sulfanyl-5-morpholin-4-ylsulfonyl-N-(oxolan-2-ylmethyl)benzamide | —— | C22H25BrN2O5S2 |
|
—— | 2-[(4-Bromophenyl)sulfanyl]-N-[2-(morpholin-4-YL)ethyl]-5-(morpholine-4-sulfonyl)benzamide | —— | C23H28BrN3O5S2 |
|
—— | N-(1,3-benzodioxol-5-ylmethyl)-2-(4-bromophenyl)sulfanyl-5-morpholin-4-ylsulfonylbenzamide | —— | C25H23BrN2O6S2 |
|
—— | (2R)-2-(4-fluorophenyl)-2-phenylsulfanylethanamine | —— | C14H14FNS |
|
—— | (1S,2R)-1-(4-fluorophenyl)-1-(1H-1,2,4-triazol-5-ylsulfanyl)butan-2-amine | —— | C12H15FN4S |
|
—— | (2S)-N-cyclooctyl-3-methyl-2-(1-oxidopyridin-1-ium-2-yl)sulfanylbutanamide | —— | C18H28N2O2S |
|
—— | 2-[(4-Bromophenyl)sulfanyl]-5-[(3,5-dimethylpiperidino)sulfonyl]-N-(2-methoxyethyl)benzamide | —— | C23H29BrN2O4S2 |
|
—— | 2-[(4-Bromophenyl)sulfanyl]-5-[(3,5-dimethylpiperidin-1-YL)sulfonyl]-N-(3-ethoxypropyl)benzamide | —— | C25H33BrN2O4S2 |
|
—— | N-(2,2-Dimethoxyethyl)-5-[(3,5-dimethylpiperidin-1-YL)sulfonyl]-2-[(4-fluorophenyl)sulfanyl]benzamide | —— | C24H31FN2O5S2 |
|
—— | 2-[(1R)-2-amino-1-(4-methylphenyl)ethyl]sulfanylpyrimidine-4,6-diamine | —— | C13H17N5S |
|
—— | (2R)-2-(2-bromophenyl)sulfanyl-2-(4-methylphenyl)ethanamine | —— | C15H16BrNS |
|
—— | (2R)-2-(4-methylphenyl)-2-[(5-methyl-1H-1,2,4-triazol-3-yl)sulfanyl]ethanamine | —— | C12H16N4S |
|
—— | 2-[(1S)-2-amino-1-(4-methylphenyl)ethyl]sulfanylpyrimidine-4,6-diamine | —— | C13H17N5S |
|
—— | (2R)-2-(4-fluorophenyl)sulfanyl-2-(4-methylphenyl)ethanamine | —— | C15H16FNS |
|
—— | (2S)-2-(3,4-dimethylphenyl)sulfanyl-2-(4-methylphenyl)ethanamine | —— | C17H21NS |
|
—— | (2S)-2-(3,4-difluorophenyl)sulfanyl-2-(4-methylphenyl)ethanamine | —— | C15H15F2NS |
|
—— | (2R)-2-(4-methylphenyl)-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]ethanamine | —— | C12H16N4S |
|
—— | (2S)-2-(4-methylphenyl)-2-(1-methyltetrazol-5-yl)sulfanylethanamine | —— | C11H15N5S |
|
—— | (2S)-2-phenyl-2-(1,3-thiazol-2-ylsulfanyl)ethanamine | —— | C11H12N2S2 |
|
—— | (2R)-2-(4-methylphenyl)-2-(2-methylphenyl)sulfanylethanamine | —— | C16H19NS |
|
—— | (2R)-2-(2-chlorophenyl)sulfanyl-2-(4-methylphenyl)ethanamine | —— | C15H16ClNS |
|
—— | (2S)-2-(4-methylphenyl)-2-pyrimidin-2-ylsulfanylethanamine | —— | C13H15N3S |
|
—— | 2-[(1S)-2-amino-1-phenylethyl]sulfanyl-6-methyl-1H-pyrimidin-4-one | —— | C13H15N3OS |
|
—— | 2-[(4-Bromophenyl)sulfanyl]-N-(2,2-dimethoxyethyl)-5-[(3,5-dimethylpiperidin-1-YL)sulfonyl]benzamide | —— | C24H31BrN2O5S2 |
|
—— | (2S)-2-(1-methylimidazol-2-yl)sulfanyl-2-phenylethanamine | —— | C12H15N3S |
|
—— | 2-[(3-Chlorophenyl)sulfanyl]-N-(2,2-dimethoxyethyl)-5-[(3,5-dimethylpiperidin-1-YL)sulfonyl]benzamide | —— | C24H31ClN2O5S2 |
|
—— | (2R)-2-(2-methylphenyl)sulfanyl-2-phenylethanamine | —— | C15H17NS |
|
—— | (2S)-2-(4-bromophenyl)sulfanyl-2-phenylethanamine | —— | C14H14BrNS |
|
—— | 2-[[6-(Furan-2-ylmethyl)-7-oxo-3-(2-phenylethyl)-2-sulfanylidene-[1,3]thiazolo[4,5-d]pyrimidin-5-yl]sulfanyl]acetonitrile | —— | C20H16N4O2S3 |
|
—— | 2-(4-bromophenyl)sulfanyl-N-(2,3-dihydro-1,4-benzodioxin-3-yl)-5-morpholin-4-ylsulfonylbenzamide | —— | C25H23BrN2O6S2 |
|
—— | 5-[2-(3-Amino-5-methylpyrazol-1-yl)-2-oxoethyl]sulfanyl-6-(4-fluorophenyl)-3-(furan-2-ylmethyl)-2-sulfanylidene-[1,3]thiazolo[4,5-d]pyrimidin-7-one | —— | C22H17FN6O3S3 |
|
—— | 5-[2-(3-Amino-5-methylpyrazol-1-yl)-2-oxoethyl]sulfanyl-6-(4-fluorophenyl)-3-(oxolan-2-ylmethyl)-2-sulfanylidene-[1,3]thiazolo[4,5-d]pyrimidin-7-one | —— | C22H21FN6O3S3 |
|
—— | 2-[[3-(4-ethylphenyl)-7-oxo-2-sulfanylidene-6H-[1,3]thiazolo[4,5-d]pyrimidin-5-yl]sulfanyl]acetic acid | —— | C15H13N3O3S3 |
|
—— | ethyl 2-[(7-oxo-3-phenyl-2-sulfanylidene-4H-[1,3]thiazolo[4,5-d]pyrimidin-5-yl)sulfanyl]acetate | —— | C15H13N3O3S3 |
|
—— | (2R)-2-(3,4-dimethylphenyl)sulfanyl-2-phenylethanamine | —— | C16H19NS |
|
—— | (2S)-2-methyl-3-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)sulfanyl]propanoic acid | —— | C10H10N2O3S2 |
|
—— | (2S)-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-2-phenylethanamine | —— | C11H14N4S |
|